| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:1795-1801.)
© 2004 American Heart Association, Inc.
Basic Science Reports |
From the Institut für Kardiovaskuläre Physiologie (O.J., J.G.S., R.B., R.P.B.) and Medizinische Klinik IV, Funktionsbereich Nephrologie (H.G.), Klinikum der J.W. Goethe-Universität, Frankfurt am Main, Germany, and the Division of Hypertension, University of Lausanne Medical School, Lausanne, Switzerland (T.P.).
Correspondence to Ralf P. Brandes, MD, Institut für Kardiovaskuläre Physiologie, Klinikum der J.W. Goethe-Universität, Theodor-Stern-Kai 7, D-60596 Frankfurt am Main, Germany. E-mail r.brandes{at}em.uni-frankfurt.de
Received June 16, 2003; de novo received November 6, 2003; accepted January 5, 2004.
Background Isoforms of the NADPH oxidase contribute to vascular superoxide anion ( · O2) formation and limit NO bioavailability. We hypothesized that the endothelial gp91phox-containing NADPH oxidase is predominant in generating the O2 to scavenge endothelial NO and thus is responsible for the development of endothelial dysfunction.
Methods and Results Endothelial dysfunction was studied in aortic rings from wild-type (WT) and gp91phox-knockout (gp91phox/) mice with and without renovascular hypertension induced by renal artery clipping (2K1C). Hypertension induced by 2K1C was more severe in WT than in gp91phox/ mice (158±2 versus 149±2 mm Hg; P<0.05). Endothelium-dependent relaxation to acetylcholine (ACh) was attenuated in rings from clipped WT but not from clipped gp91phox/ mice. The reactive oxygen species (ROS) scavenger Tiron, PEG-superoxide dismutase, and the NADPH oxidase inhibitory peptide gp91ds-tat enhanced ACh-induced relaxation in aortae of clipped WT mice. Inhibition of protein kinase C, Rac, and the epidermal growth factor receptor kinase, elements involved in the activation of the NADPH oxidase, restored normal endothelium-dependent relaxation in vessels from clipped WT mice but had no effect on relaxations in those from gp91phox/ mice. Relaxations to exogenous NO were attenuated in vessels from clipped WT but not clipped gp91phox/ mice. After removal of the endothelium or treatment with PEG-superoxide dismutase, NO-induced relaxations were identical in vessels from clipped and sham-operated WT and gp91phox mice.
Conclusions These data indicate that the formation of O2 by the endothelial gp91phox-containing NADPH oxidase accounts for the reduced NO bioavailability in the 2K1C model and contributes to the development of renovascular hypertension and endothelial dysfunction.
Key Words: stress, oxidative angiotensin endothelium hypertension
This article has been cited by other articles:
![]() |
A. E. Loot, J. G. Schreiber, B. Fisslthaler, and I. Fleming Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase J. Exp. Med., November 23, 2009; (2009) jem.20090449v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Jenkins, S. Witkowski, E. E. Spangenburg, and J. M. Hagberg Effects of acute and chronic endurance exercise on intracellular nitric oxide in putative endothelial progenitor cells: role of NAPDH oxidase Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1798 - H1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Violi, V. Sanguigni, R. Carnevale, A. Plebani, P. Rossi, A. Finocchi, C. Pignata, D. De Mattia, B. Martire, M. C. Pietrogrande, et al. Hereditary Deficiency of gp91phox Is Associated With Enhanced Arterial Dilatation: Results of a Multicenter Study Circulation, October 20, 2009; 120(16): 1616 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, S. Wang, Y. Wu, P. Song, and M.-H. Zou Tyrosine Nitration of PA700 Activates the 26S Proteasome to Induce Endothelial Dysfunction in Mice With Angiotensin II-Induced Hypertension Hypertension, September 1, 2009; 54(3): 625 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ryan Young Investigator Award Lecture of the APS Water and Electrolyte Homeostasis Section, 2008: The pathophysiology of hypertension in systemic lupus erythematosus Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1258 - R1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carlstrom, E. Y. Lai, Z. Ma, A. Patzak, R. D. Brown, and A. E. G. Persson Role of NOX2 in the regulation of afferent arteriole responsiveness Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R72 - R79. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, P. Malik, D. Pandey, S. Gupta, D. Jagnandan, E. B. de Chantemele, B. Banfi, M. B. Marrero, R. D. Rudic, D. W. Stepp, et al. Paradoxical Activation of Endothelial Nitric Oxide Synthase by NADPH Oxidase Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1627 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Paravicini and R. M. Touyz NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Schrader, D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion IL-6 Deficiency Protects Against Angiotensin II Induced Endothelial Dysfunction and Hypertrophy Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2576 - 2581. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Korshunov, M. Daul, M. P. Massett, and B. C. Berk Axl Mediates Vascular Remodeling Induced by Deoxycorticosterone Acetate Salt Hypertension Hypertension, December 1, 2007; 50(6): 1057 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kahles, P. Luedike, M. Endres, H.-J. Galla, H. Steinmetz, R. Busse, T. Neumann-Haefelin, and R. P. Brandes NADPH Oxidase Plays a Central Role in Blood-Brain Barrier Damage in Experimental Stroke Stroke, November 1, 2007; 38(11): 3000 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Yang, M.-C. Ma, C.-T. Chien, M.-S. Wu, W.-K. Sun, and C.-F. Chen Hypoxic preconditioning attenuates lipopolysaccharide-induced oxidative stress in rat kidneys J. Physiol., July 1, 2007; 582(1): 407 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Bendall, R. Rinze, D. Adlam, A. L. Tatham, J. de Bono, and K. M. Channon Endothelial Nox2 Overexpression Potentiates Vascular Oxidative Stress and Hemodynamic Response to Angiotensin II: Studies in Endothelial-Targeted Nox2 Transgenic Mice Circ. Res., April 13, 2007; 100(7): 1016 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Violi, V. Sanguigni, L. Loffredo, R. Carnevale, B. Buchetti, A. Finocchi, M. Tesauro, P. Rossi, and P. Pignatelli Nox2 is determinant for ischemia-induced oxidative stress and arterial vasodilatation: a pilot study in patients with hereditary Nox2 deficiency. Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): e131 - e132. [Full Text] [PDF] |
||||
![]() |
T. M. Paravicini and R. M. Touyz Redox signaling in hypertension Cardiovasc Res, July 15, 2006; 71(2): 247 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nakano, C.-J. Kwak, K. Fujii, K. Ikemura, A. Satake, M. Ohkita, M. Takaoka, Y. Ono, M. Nakai, N. Tomimori, et al. Sesamin Metabolites Induce an Endothelial Nitric Oxide-Dependent Vasorelaxation through Their Antioxidative Property-Independent Mechanisms: Possible Involvement of the Metabolites in the Antihypertensive Effect of Sesamin J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 328 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wang, H. Singh, F. Zhang, T. Ishizuka, H. Deng, R. Kemp, M. S. Wolin, T. H. Hintze, N. G. Abraham, A. Nasjletti, et al. Endothelial Dysfunction and Hypertension in Rats Transduced With CYP4A2 Adenovirus Circ. Res., April 14, 2006; 98(7): 962 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Hordijk Regulation of NADPH Oxidases: The Role of Rac Proteins Circ. Res., March 3, 2006; 98(4): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Browe and C. M. Baumgarten EGFR Kinase Regulates Volume-sensitive Chloride Current Elicited by Integrin Stretch via PI-3K and NADPH Oxidase in Ventricular Myocytes J. Gen. Physiol., February 27, 2006; 127(3): 237 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, D. A. Kinzenbaw, and F. M. Faraci Critical Role for CuZn-Superoxide Dismutase in Preventing Angiotensin II-Induced Endothelial Dysfunction Hypertension, November 1, 2005; 46(5): 1147 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhan, F. Serrano, P. Fenik, R. Hsu, L. Kong, D. Pratico, E. Klann, and S. C. Veasey NADPH Oxidase Mediates Hypersomnolence and Brain Oxidative Injury in a Murine Model of Sleep Apnea Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kinugawa, J. Zhang, E. Messina, E. Walsh, H. Huang, P. M. Kaminski, M. S. Wolin, and T. H. Hintze gp91phox-containing NAD(P)H oxidase mediates attenuation of nitric oxide-dependent control of myocardial oxygen consumption by ANG II Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H862 - H867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Bowers, K. A. Katki, A. Rao, M. Koehler, P. Patel, A. Spiekerman, D. J. DiPette, and S. C. Supowit Role of Calcitonin Gene-Related Peptide in Hypertension-Induced Renal Damage Hypertension, July 1, 2005; 46(1): 51 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Brandes, I. Fleming, and R. Busse Endothelial aging Cardiovasc Res, May 1, 2005; 66(2): 286 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz, C. Mercure, Y. He, D. Javeshghani, G. Yao, G. E. Callera, A. Yogi, N. Lochard, and T. L. Reudelhuber Angiotensin II-Dependent Chronic Hypertension and Cardiac Hypertrophy Are Unaffected by gp91phox-Containing NADPH Oxidase Hypertension, April 1, 2005; 45(4): 530 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Adams, A. Linke, N. Krankel, S. Erbs, S. Gielen, S. Mobius-Winkler, J. F. Gummert, F. W. Mohr, G. Schuler, and R. Hambrecht Impact of Regular Physical Activity on the NAD(P)H Oxidase and Angiotensin Receptor System in Patients With Coronary Artery Disease Circulation, February 8, 2005; 111(5): 555 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Brandes and J. Kreuzer Vascular NADPH oxidases: molecular mechanisms of activation Cardiovasc Res, January 1, 2005; 65(1): 16 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wassmann, T. Czech, M. van Eickels, I. Fleming, M. Bohm, and G. Nickenig Inhibition of Diet-Induced Atherosclerosis and Endothelial Dysfunction in Apolipoprotein E/Angiotensin II Type 1A Receptor Double-Knockout Mice Circulation, November 9, 2004; 110(19): 3062 - 3067. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Park, J. Anrather, P. Zhou, K. Frys, G. Wang, and C. Iadecola Exogenous NADPH Increases Cerebral Blood Flow Through NADPH Oxidase-Dependent and -Independent Mechanisms Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1860 - 1865. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Brandes And What About the Endothelium?: On the Predominance of Cerebral Superoxide Formation for Angiotensin II-Induced Systemic Hypertension Circ. Res., July 23, 2004; 95(2): 122 - 124. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |